Looking Beyond the Diagnosis
Your diagnosis is only one part of the picture. Molecular profiling, pathology findings, imaging, and your medical history together provide a deeper understanding of your cancer.
Cancer Treatments
Understanding Precision Oncology
No two cancers are exactly alike, even when they affect the same organ. Advances in cancer research have shown that the unique genetic and molecular characteristics of a tumour can influence how it behaves and how it responds to treatment. Understanding these differences allows treatment to move beyond a standard approach and become more individualised.
Precision Oncology is an advanced approach to cancer care that uses genomic testing, molecular profiling, biomarker analysis, and clinical expertise to help identify the most appropriate treatment for each patient. Rather than asking "What treatment is usually given?", precision oncology asks "What treatment is most likely to work for this individual?"
At IOHC, precision oncology forms the foundation of personalised cancer care. By bringing together advanced diagnostics, multidisciplinary expertise, and evidence-based decision-making, we aim to recommend treatments that are better aligned with your diagnosis, biology, and long-term treatment goals.
When Can Precision Oncology Make a Difference?
Precision oncology is considered when additional molecular or genomic information can help guide treatment decisions. Depending on the type of cancer, this approach may identify therapies that are more effective, help avoid unnecessary treatments, or provide access to newer treatment strategies where appropriate.
Your oncologist may recommend precision oncology if:
- Your cancer may benefit from genomic or biomarker testing.
- Treatment decisions require additional molecular information.
- Targeted therapy or immunotherapy is being considered.
- Previous treatments have not achieved the desired outcome.
- A more personalised treatment strategy is appropriate for your diagnosis.
Building Treatment Around Your Biology
Precision oncology begins by understanding what makes your cancer unique. Every recommendation is informed by scientific evidence, advanced diagnostics, and a multidisciplinary review that helps identify the treatment most suited to your condition.
Using Genomic and Biomarker Insights
Advanced genomic testing for cancer and biomarker testing help identify genetic changes that may influence treatment decisions, allowing your care team to recommend therapies with greater confidence.
Personalising Every Treatment Decision
The information gathered through precision medicine for cancer helps determine whether treatments such as targeted therapy, immunotherapy, chemotherapy, or clinical trials may be appropriate for your condition.
Reviewing Your Progress
Cancer care continues to evolve throughout treatment. Regular clinical reviews and ongoing assessments help monitor your response and refine treatment decisions whenever necessary.
Adapting Care as Your Needs Change
Your treatment plan is reviewed at every stage to ensure it continues to reflect your diagnosis, your response to treatment, and the latest clinical evidence available.
Preparing for Precision Oncology
Precision oncology begins with understanding your cancer in greater detail. Staying engaged with your care plan, completing the recommended investigations, and sharing changes in your health all help your oncology team make informed treatment decisions throughout your care.
Do's
- Complete all recommended genomic, biomarker, or molecular tests.
- Keep your pathology reports, scans, and medical records organised.
- Share any new symptoms or changes in your health during treatment.
- Attend scheduled follow-up appointments and review consultations.
- Ask questions to better understand how your test results influence treatment decisions.
Don'ts
- Do not delay recommended diagnostic or genomic investigations.
- Avoid making treatment decisions without discussing them with your oncology team.
- Do not ignore follow-up appointments, even if you are feeling well.
- Avoid relying on generic treatment information that may not apply to your diagnosis.
- Do not start or stop medications without medical advice.
Care That Evolves with Every Decision
Precision oncology is not a single test or treatment. As your diagnosis, response to therapy, and clinical findings evolve, your treatment plan may evolve too.
At IOHC, precision oncology brings together genomic insights, multidisciplinary expertise, and continuous clinical review to support informed decision-making at every stage of care. Whether treatment involves chemotherapy, immunotherapy, targeted therapy, or another advanced approach, every recommendation is guided by the latest evidence and your individual needs.
Request AppointmentFrequently Asked Questions
Questions About Precision Oncology
Precision Oncology is an advanced approach to personalised cancer treatment that uses genomic testing, molecular profiling, and biomarker analysis to understand the unique characteristics of a patient's cancer. These insights help doctors recommend treatments that are more closely matched to the biology of the tumour.
Precision oncology helps to:
- Guide personalised treatment decisions.
- Identify suitable targeted treatment options.
- Support evidence-based cancer care.
While Precision Oncology is an approach to selecting the most appropriate treatment, targeted therapy for cancer is one of the treatments that may be recommended based on genomic or biomarker findings. Precision medicine for cancer helps determine which therapies are most suitable for an individual patient.
Precision oncology involves:
- Genomic and molecular testing.
- Biomarker-guided treatment planning.
- Personalised treatment selection.
Many patients may benefit from precision oncology treatment, particularly when additional genomic or molecular information can help guide treatment decisions. Your oncologist will determine whether molecular profiling or genomic testing is appropriate based on your diagnosis.
It may be recommended for:
- Certain solid tumours.
- Selected blood cancers.
- Patients requiring personalised treatment planning.
Genomic testing for cancer looks for genetic changes within cancer cells that may influence treatment decisions. Combined with molecular profiling, it helps your oncology team identify therapies that may be more effective for your specific diagnosis.
Genomic testing may help:
- Identify genetic alterations.
- Support personalised treatment planning.
- Guide targeted therapy decisions.
Not every cancer requires precision oncology, and not every patient will need genomic testing. The decision depends on the type of cancer, available biomarkers, and whether precision oncology treatment is likely to influence your treatment plan.
Your oncologist considers:
- The type and stage of cancer.
- Available molecular markers.
- Your overall treatment goals.
Treatment decisions in precision oncology are based on a combination of clinical expertise, pathology findings, imaging, genomic testing, and biomarker analysis. These findings are reviewed together to recommend the most appropriate treatment for your condition.
The decision-making process includes:
- Clinical evaluation.
- Genomic and biomarker testing.
- Multidisciplinary treatment planning.
Yes. One of the strengths of precision oncology is that treatment decisions can evolve as new clinical information becomes available. Through regular reviews and personalised cancer treatment planning, your oncology team can adapt your care to reflect your response to treatment and the latest scientific evidence.
Your care plan may change based on:
- Your response to treatment.
- New diagnostic findings.
- Updated clinical recommendations.
Related Cancer Treatments
Visit IOHC — Mumbai
1101, 11th Floor, Shrikant Chamber-2 Next to R.K Studio, Union Park, Chembur Mumbai, Maharashtra 400071
Get Directions